Cancer diagnostics company, Pacific Edge, has reported resilient demand for its tests in the three months to the end of June 2025, despite the loss of Medicare coverage in April 2025 and the ...

Overall, 35% of patients' records had evidence of comprehensive genomic profiling (CGP). The rate increased modestly from 32% at the beginning of the study period to 39% at the end, reported Stacey ...

A recent study shows that cancer survivors’ out-of-pocket costs for necessary medical equipment are sometimes so high that ...

With half a million people having already received multi-cancer early detection (MCED) screening, patients are and will continue to be asking about these blood tests during their visits, physicians ...

Cancer survivors who received high-cost immunotherapies appear more likely to experience financial hardship, according to ...

A test developed by a Madison company to better track cancer DNA in the blood stream will now be covered by Medicare.

The recommended age to start screening for colorectal cancer was lowered in 2021 from 50 to 45 for people of average risk.

Adam Gray (D-CA), and Neal Dunn (R-FL) introduced the Protecting Patient Access to Cancer and Complex Therapies Act. This legislation would revert physician reimbursement for administering drugs under ...

Federal prosecutors said that Shayasta Mufti submitted $1.7 million in Medicare claims without examining or assessing the patients tested.

The test is covered for serial use in patients with colorectal cancer in the adjuvant and recurrence monitoring settings over a five-year period.

Dr. Alexandra Zaleta discussed the impact of administrative delays and insurance red tape experienced by patients with ...

An Alabama woman drove to Tampa for answers about her late father’s missing money. Money that she said was siphoned by ...